Servier targeted by fresh claims from UK health authorities
MLex Summary: Servier Laboratories has been targeted by fresh claims from UK health authorities over alleged anticompetitive agreements for the blood pressure medication perindopril, according to filings with the Competition Appeal Tribunal....To view the full article, register now.
Already a subscriber? Click here to view full article